A detailed history of Blue Spruce Investments, LP transactions in Zoetis Inc. stock. As of the latest transaction made, Blue Spruce Investments, LP holds 752,351 shares of ZTS stock, worth $110 Million. This represents 2.73% of its overall portfolio holdings.

Number of Shares
752,351
Previous 3,457 21663.12%
Holding current value
$110 Million
Previous $569,000 20520.21%
% of portfolio
2.73%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$144.41 - $170.3 $108 Million - $128 Million
748,894 Added 21663.12%
752,351 $117 Million
Q1 2025

May 15, 2025

SELL
$156.48 - $175.67 $160,861 - $180,588
-1,028 Reduced 22.92%
3,457 $569,000
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $652,746 - $802,052
4,485 New
4,485 $777,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $68.4B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Blue Spruce Investments, LP Portfolio

Follow Blue Spruce Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Spruce Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Blue Spruce Investments, LP with notifications on news.